chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity, Paraesthesia, SARS-CoV-2 test positive, Sensory loss
Clinical narrative: This is a spontaneous report from a contactable consumer. A 60-year-old female patient started to receive bnt162b2 (manufacturer unspecified), lot number: EL4238, via an unspecified route of administration in the left arm, on 21Jan2021 15:00 at SINGLE DOSE for COVID-19 immunization. Medical history included arthritis. Patient's known allergies are Penicillin, Peanut and Dairy. Patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient hasn't been tested for COVID-19. There were no concomitant medications.  The patient's whole/entire arm was killing her; she was hurting across her shoulder blades down to fingers. Her elbow and wrist were hot and she was feeling a tremble in hand which she has never had before. She later added that her joint in elbow and shoulder was now reaching down to her arm. She couldn't even wear her watch today to her work, it felt swollen, like there was liquid in it. She also can't lift her arm, move and the pain was like going into her back. The patient was taking Aleve and Advil and "it doesn't take away all but it takes away enough that she can function." She also bought a topical ointment to help numb the area and she was wearing a pain patch on my back. The outcome of events was reported as 'not recovered'. No follow-up attempts are possible. No further information is expected. Information on the batch/lot number has been obtained.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Night sweats, Pain in extremity
Clinical narrative: sore arm; terrible chills; night sweats; This is a spontaneous report from a contactable consumer, the patient.  A 55-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration on 22Jan2021 at 12:15 (at the age of 55 years-old) in the left arm as a single dose for COVID-19 immunisation. Medical history included Behcet's disease and penicillin allergy; from unknown dates and unknown if ongoing. Prior to the vaccination, the patient was diagnosed with COVID-19 from an unknown date and unknown if ongoing.   Concomitant medications included adalimumab (HUMIRA), testosterone (MANUFACTURER UNKNOWN), citalopram hydrobromide (CELEXA), dexlansoprazole (DEXILANT), and paracetamol (TYLENOL); all taken for unknown indications from unknown dates and unknown if ongoing.  It was unknown whether the patient received any other vaccine within 4 weeks prior to the vaccine.  The patient previously took sumatriptan (IMITREX) from an unknown date to an unknown date and experienced allergy.  On 23Jan2021, the patient experienced sore arm, terrible chills, and night sweats. The patient did not receive any treatment for the events. The clinical outcomes sore arm, terrible chills, and night sweats was recovering.   The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Back pain, Body temperature, Body temperature increased
Clinical narrative: This is a spontaneous report from a contactable other health professional.  A 59-year-old patient received the second dose of the bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: EL1283), via an unspecified route of administration in the left arm on 22Jan2021 at 17:00 at 59-years-old at a single dose for COVID-19 immunization; administered in a hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Medical history included pneumothorax from an unknown date and unknown if ongoing, asthma from an unknown date and unknown if ongoing, COVID-19 from an unknown date and unknown if ongoing (Prior to vaccination).  Concomitant medications included bupropion hydrochloride (WELLBUTRIN), desvenlafaxine succinate (PRISTIQ), meloxicam (MANUFACTURER UNKNOWN); taken for an unspecified indication from an unspecified date to an unspecified date (received within 2 weeks of vaccination).  The patient previously took diphenhydramine hydrochloride (BENADRYL) and fluticasone propionate, salmeterol xinafoate (ADVAIR diskus) and experienced allergy from an unknown date and unknown if ongoing. The patient previously received the first dose of the bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: unknown) for COVID-19 immunization on an unknown date. On 23Jan2021 at 04:00, the patient experienced: temp 101.7 which held for 28 hrs, then 100.7 for 24 hrs, now at 99.4 (non-serious), severe back pain (non-serious), severe joint swelling in hands (non-serious), severe headache (non-serious), severe body aches and pain (non-serious), right foot felt like bones were broken when walking (non-serious), coughing (non-serious), increased phlegm production (non-serious), loss of taste (non-serious), loss of smell (non-serious); in which no treatment was received. The patient, however, went to a doctor or other healthcare professional office/clinic visit.  The patient underwent lab tests and procedures which included temperature: 100.7 in Jan2021 for 24 hrs, temperature: 101.7   on 23Jan2021 held for 28 hrs, temperature: 99.4 on 26Jan2021.  The clinical outcome of the events was not recovered. Since the vaccination, the patient has not been tested for COVID-19.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Headache, Joint swelling, Limb discomfort, Pain
Clinical narrative: This is a spontaneous report from a contactable other health professional.  A 59-year-old patient received the second dose of the bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: EL1283), via an unspecified route of administration in the left arm on 22Jan2021 at 17:00 at 59-years-old at a single dose for COVID-19 immunization; administered in a hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Medical history included pneumothorax from an unknown date and unknown if ongoing, asthma from an unknown date and unknown if ongoing, COVID-19 from an unknown date and unknown if ongoing (Prior to vaccination).  Concomitant medications included bupropion hydrochloride (WELLBUTRIN), desvenlafaxine succinate (PRISTIQ), meloxicam (MANUFACTURER UNKNOWN); taken for an unspecified indication from an unspecified date to an unspecified date (received within 2 weeks of vaccination).  The patient previously took diphenhydramine hydrochloride (BENADRYL) and fluticasone propionate, salmeterol xinafoate (ADVAIR diskus) and experienced allergy from an unknown date and unknown if ongoing. The patient previously received the first dose of the bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: unknown) for COVID-19 immunization on an unknown date. On 23Jan2021 at 04:00, the patient experienced: temp 101.7 which held for 28 hrs, then 100.7 for 24 hrs, now at 99.4 (non-serious), severe back pain (non-serious), severe joint swelling in hands (non-serious), severe headache (non-serious), severe body aches and pain (non-serious), right foot felt like bones were broken when walking (non-serious), coughing (non-serious), increased phlegm production (non-serious), loss of taste (non-serious), loss of smell (non-serious); in which no treatment was received. The patient, however, went to a doctor or other healthcare professional office/clinic visit.  The patient underwent lab tests and procedures which included temperature: 100.7 in Jan2021 for 24 hrs, temperature: 101.7   on 23Jan2021 held for 28 hrs, temperature: 99.4 on 26Jan2021.  The clinical outcome of the events was not recovered. Since the vaccination, the patient has not been tested for COVID-19.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Productive cough
Clinical narrative: This is a spontaneous report from a contactable other health professional.  A 59-year-old patient received the second dose of the bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: EL1283), via an unspecified route of administration in the left arm on 22Jan2021 at 17:00 at 59-years-old at a single dose for COVID-19 immunization; administered in a hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Medical history included pneumothorax from an unknown date and unknown if ongoing, asthma from an unknown date and unknown if ongoing, COVID-19 from an unknown date and unknown if ongoing (Prior to vaccination).  Concomitant medications included bupropion hydrochloride (WELLBUTRIN), desvenlafaxine succinate (PRISTIQ), meloxicam (MANUFACTURER UNKNOWN); taken for an unspecified indication from an unspecified date to an unspecified date (received within 2 weeks of vaccination).  The patient previously took diphenhydramine hydrochloride (BENADRYL) and fluticasone propionate, salmeterol xinafoate (ADVAIR diskus) and experienced allergy from an unknown date and unknown if ongoing. The patient previously received the first dose of the bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: unknown) for COVID-19 immunization on an unknown date. On 23Jan2021 at 04:00, the patient experienced: temp 101.7 which held for 28 hrs, then 100.7 for 24 hrs, now at 99.4 (non-serious), severe back pain (non-serious), severe joint swelling in hands (non-serious), severe headache (non-serious), severe body aches and pain (non-serious), right foot felt like bones were broken when walking (non-serious), coughing (non-serious), increased phlegm production (non-serious), loss of taste (non-serious), loss of smell (non-serious); in which no treatment was received. The patient, however, went to a doctor or other healthcare professional office/clinic visit.  The patient underwent lab tests and procedures which included temperature: 100.7 in Jan2021 for 24 hrs, temperature: 101.7   on 23Jan2021 held for 28 hrs, temperature: 99.4 on 26Jan2021.  The clinical outcome of the events was not recovered. Since the vaccination, the patient has not been tested for COVID-19.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Blood pressure measurement, Dysgeusia, Dysphagia, Hypoaesthesia
Clinical narrative: tingling sensation in jaw and it extended to nose and it felt numb with difficulty swallowing; tingling sensation in jaw and it extended to nose and it felt numb with difficulty swallowing; tingling sensation in jaw and it extended to nose and it felt numb with difficulty swallowing; raised blood pressure; metallic taste; This is a spontaneous report from a contactable healthcare professional.  A 46-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number 0041297301), via an unspecified route of administration in left arm on 15Jan2021, at 17:00 as  first single dose for covid-19 immunisation.  Medical history included obesity, opiate allergy and artichokes  allergy from an unknown date.  Concomitant medication included  unspecified probiotic, levothyroxine (MANUFACTURER UNKNOWN), ascorbic acid (VIT C), ergocalciferol (VIT D), linum usitatissimum seed oil (FLAXSEED OIL NATURE MADE).  The patient experienced the following non-serious events:  metallic taste on 15Jan2021, at 17:30 with outcome of recovered in Jan2021; tingling sensation in jaw and it extended to nose and it felt numb with difficulty swallowing on 15Jan2021, at 17:30 with outcome of recovered in Jan2021; raised blood pressure on 15Jan2021, at 17:30 with outcome of recovered in Jan2021.  Details were as follows: following vaccination the patient reported a metallic taste in her mouth, then a tingling sensation in her jaw which extended to her nose and it felt numb with difficulty swallowing, and she also had raised blood pressure. No  treatment  was received for the adverse events. Prior to vaccination, the patient was not diagnosed with COVID-19, and since the vaccination, the patient has not been tested for COVID-19.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: tingling sensation in jaw and it extended to nose and it felt numb with difficulty swallowing; tingling sensation in jaw and it extended to nose and it felt numb with difficulty swallowing; tingling sensation in jaw and it extended to nose and it felt numb with difficulty swallowing; raised blood pressure; metallic taste; This is a spontaneous report from a contactable healthcare professional.  A 46-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number 0041297301), via an unspecified route of administration in left arm on 15Jan2021, at 17:00 as  first single dose for covid-19 immunisation.  Medical history included obesity, opiate allergy and artichokes  allergy from an unknown date.  Concomitant medication included  unspecified probiotic, levothyroxine (MANUFACTURER UNKNOWN), ascorbic acid (VIT C), ergocalciferol (VIT D), linum usitatissimum seed oil (FLAXSEED OIL NATURE MADE).  The patient experienced the following non-serious events:  metallic taste on 15Jan2021, at 17:30 with outcome of recovered in Jan2021; tingling sensation in jaw and it extended to nose and it felt numb with difficulty swallowing on 15Jan2021, at 17:30 with outcome of recovered in Jan2021; raised blood pressure on 15Jan2021, at 17:30 with outcome of recovered in Jan2021.  Details were as follows: following vaccination the patient reported a metallic taste in her mouth, then a tingling sensation in her jaw which extended to her nose and it felt numb with difficulty swallowing, and she also had raised blood pressure. No  treatment  was received for the adverse events. Prior to vaccination, the patient was not diagnosed with COVID-19, and since the vaccination, the patient has not been tested for COVID-19.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Chills, Dizziness, Fatigue
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 19Jan2021 at SINGLE DOSE for COVID-19 immunization. The patient's medical history and concomitant medications were not reported.  The patient stated that she almost had all the side effects: she has no energy, been laying around for 6 days and felt like she have the flu or a cold, Thursday night (unspecified date), she had injection site pain, felt tired, has headache, muscle pain, chills, joint pain and fever. She has gotten better but now she has headache and can't get out of bed, feel dizzy. The patient recovered from the chills and fever on an unspecified date. Outcome of other events was not recovered and she was wondering when will all the other symptoms will go away, The patient was scheduled for 2nd dose on 14Feb2021. Follow-up attempts are completed. The following information on the batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Influenza like illness, Myalgia, Pyrexia, Vaccination site pain
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 19Jan2021 at SINGLE DOSE for COVID-19 immunization. The patient's medical history and concomitant medications were not reported.  The patient stated that she almost had all the side effects: she has no energy, been laying around for 6 days and felt like she have the flu or a cold, Thursday night (unspecified date), she had injection site pain, felt tired, has headache, muscle pain, chills, joint pain and fever. She has gotten better but now she has headache and can't get out of bed, feel dizzy. The patient recovered from the chills and fever on an unspecified date. Outcome of other events was not recovered and she was wondering when will all the other symptoms will go away, The patient was scheduled for 2nd dose on 14Feb2021. Follow-up attempts are completed. The following information on the batch number has been requested.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Dizziness, Fatigue, Influenza like illness
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient.  A 22-year-old non-pregnant female patient received the second dose  of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EK9231), via an unspecified route of administration in the left arm on 25Jan2021 (at the age of 22-years-old) as a single dose for COVID-19 immunization.  Medical history included sulfa allergy, depression, and anxiety. Prior to the vaccination, the patient was not diagnosed with COVID-19.  Concomitant medications included duloxetine (MANUFACTURER UNKNOWN), citalopram (MANUFACTURER UNKNOWN), and ibuprofen (MANUFACTURER UNKNOWN). The patient previously received the first dose of BNT162B2 on 08Jan2021 (at the age of 21-years-old; Lot Number: EK9231) for COVID-19 immunization in the left arm. Since the vaccination, the patient had not been tested for COVID-19.  The patient did not receive any other vaccines (except the first dose) within four weeks prior to the vaccination.  On 25Jan2021, hours after the second dose, the patient had severe full body flu like aches, lingering joint pain/some joint, dizziness, exhaustion, and weakness. On 26Jan2021, the patient had soreness at injection sight red and swollen. The patient did not receive any treatment for the events.  The clinical outcomes of the full body flu like aches, lingering joint pain/some joint, dizziness, exhaustion, weakness, and soreness injection sight red and swollen were recovering.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Off label use, Product use issue, Vaccination site erythema, Vaccination site pain, Vaccination site swelling
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient.  A 22-year-old non-pregnant female patient received the second dose  of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EK9231), via an unspecified route of administration in the left arm on 25Jan2021 (at the age of 22-years-old) as a single dose for COVID-19 immunization.  Medical history included sulfa allergy, depression, and anxiety. Prior to the vaccination, the patient was not diagnosed with COVID-19.  Concomitant medications included duloxetine (MANUFACTURER UNKNOWN), citalopram (MANUFACTURER UNKNOWN), and ibuprofen (MANUFACTURER UNKNOWN). The patient previously received the first dose of BNT162B2 on 08Jan2021 (at the age of 21-years-old; Lot Number: EK9231) for COVID-19 immunization in the left arm. Since the vaccination, the patient had not been tested for COVID-19.  The patient did not receive any other vaccines (except the first dose) within four weeks prior to the vaccination.  On 25Jan2021, hours after the second dose, the patient had severe full body flu like aches, lingering joint pain/some joint, dizziness, exhaustion, and weakness. On 26Jan2021, the patient had soreness at injection sight red and swollen. The patient did not receive any treatment for the events.  The clinical outcomes of the full body flu like aches, lingering joint pain/some joint, dizziness, exhaustion, weakness, and soreness injection sight red and swollen were recovering.
Sex: F
Vaccine: COVID19
Symptoms: Abdominal distension, Chills, Fatigue, Headache, Malaise
Clinical narrative: This is a spontaneous report from a contactable pharmacist.  A 63-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular in the left arm, on 24Jan2021 14:00 at SINGLE DOSE for covid-19 immunization.   Medical history included hypertension, covid-19 (prior to vaccination, patient was diagnosed with COVID-19), latex allergy.  Patient was not pregnant at the time of vaccination. Patient received covid-19 vaccine (lot number: EJ1686) Intramuscular in Left arm, on 02Jan2021 at 5:00pm, for covid-19 immunization and experienced only arm pain, chills, and tiredness, and headache. The first dose was much better tolerated. Concomitant medication included hydrochlorothiazide (HYDROCHLORTHIAZID), potassium chloride and calcium, colecalciferol (CITRACAL). On 25Jan2021 17:00, the patient experienced swelling at the injection site, injection site felt hot, arm pain, tiredness, chills, headache, nausea started at 27 hours (feeling bloated and nauseous), feeling unwell in general 27 hours after injection. The patient underwent lab tests and procedures on 26Jan2021, which included COVID-19 Nasopharynx: results pending.  The outcome of events was recovered. Patient did not receive any treatment for events. Since the vaccination, the patient hasn't been tested for COVID-19.  No follow-up attempts are possible. No further information is expected. Information on the batch/lot number has been obtained.
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain in extremity, SARS-CoV-2 test, Vaccination site swelling, Vaccination site warmth
Clinical narrative: This is a spontaneous report from a contactable pharmacist.  A 63-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular in the left arm, on 24Jan2021 14:00 at SINGLE DOSE for covid-19 immunization.   Medical history included hypertension, covid-19 (prior to vaccination, patient was diagnosed with COVID-19), latex allergy.  Patient was not pregnant at the time of vaccination. Patient received covid-19 vaccine (lot number: EJ1686) Intramuscular in Left arm, on 02Jan2021 at 5:00pm, for covid-19 immunization and experienced only arm pain, chills, and tiredness, and headache. The first dose was much better tolerated. Concomitant medication included hydrochlorothiazide (HYDROCHLORTHIAZID), potassium chloride and calcium, colecalciferol (CITRACAL). On 25Jan2021 17:00, the patient experienced swelling at the injection site, injection site felt hot, arm pain, tiredness, chills, headache, nausea started at 27 hours (feeling bloated and nauseous), feeling unwell in general 27 hours after injection. The patient underwent lab tests and procedures on 26Jan2021, which included COVID-19 Nasopharynx: results pending.  The outcome of events was recovered. Patient did not receive any treatment for events. Since the vaccination, the patient hasn't been tested for COVID-19.  No follow-up attempts are possible. No further information is expected. Information on the batch/lot number has been obtained.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling hot, Nausea, Pain, Pain in extremity
Clinical narrative: arm soreness; chills; body aches; feverish; nauseous; throwing up; feel very hot; This is a spontaneous report from a non-contactable consumer (patient). A 26-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3247), via an unspecified route of administration in Jan2021 at single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was not diagnosed with COVID-19 prior to vaccination. The patient is not pregnant at the time of vaccination. It was reported that upon administration of the vaccine there was arm soreness that persisted throughout the day. Around 12-14 hours after receiving the vaccine, the patient started having chills, body aches, and felt feverish. The patient also started to feel nauseous as well and ended up throwing up several times. It was reported that the adverse events started on 26Jan2021 (21:00) (as reported). The morning after (date unspecified) the symptoms resolved; however, the patient now feel very hot and the arm soreness was still present. The outcome of events arm soreness and feeling hot was not recovered, while the outcome of other events was recovered in Jan2021. The patient has not been tested for COVID-19 since the vaccination. There was no treatment received for the adverse events. The events were reported as non-serious.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: arm soreness; chills; body aches; feverish; nauseous; throwing up; feel very hot; This is a spontaneous report from a non-contactable consumer (patient). A 26-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3247), via an unspecified route of administration in Jan2021 at single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was not diagnosed with COVID-19 prior to vaccination. The patient is not pregnant at the time of vaccination. It was reported that upon administration of the vaccine there was arm soreness that persisted throughout the day. Around 12-14 hours after receiving the vaccine, the patient started having chills, body aches, and felt feverish. The patient also started to feel nauseous as well and ended up throwing up several times. It was reported that the adverse events started on 26Jan2021 (21:00) (as reported). The morning after (date unspecified) the symptoms resolved; however, the patient now feel very hot and the arm soreness was still present. The outcome of events arm soreness and feeling hot was not recovered, while the outcome of other events was recovered in Jan2021. The patient has not been tested for COVID-19 since the vaccination. There was no treatment received for the adverse events. The events were reported as non-serious.  No follow-up attempts are possible. No further information is expected.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Fatigue, Headache, Myalgia
Clinical narrative: This is a spontaneous report from a contactable nurse (patient).  A 25-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), lot number: EJ1685, via an unspecified route of administration in the right arm on 06Jan2021 12:00 at SINGLE DOSE for covid-19 immunization.  Medical history included systemic lupus, panic disorder, GERD (gastrooesophageal reflux disease) and covid-19 (Prior to vaccination, the patient was diagnosed with COVID-19). Concomitant medications included ethinylestradiol, ferrous fumarate, norethisterone acetate (JUNEL FE), omeprazole, fluoxetine, cetirizine hydrochloride (ZYRTEC).  The patient previously took lorabid and experienced allergies.  On 13Jan2021 17:00, the patient experienced fatigue, fever (101+), muscle aches, joint aches, nausea and headaches. The patient underwent lab tests and procedures on 14Jan2021 which included nasal swab: negative.  The outcome of events was recovered. Patient did not receive any treatment for the events. No follow-up attempts are possible. No further information is expected. Information on the batch/lot number has been obtained.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia, SARS-CoV-2 test
Clinical narrative: This is a spontaneous report from a contactable nurse (patient).  A 25-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), lot number: EJ1685, via an unspecified route of administration in the right arm on 06Jan2021 12:00 at SINGLE DOSE for covid-19 immunization.  Medical history included systemic lupus, panic disorder, GERD (gastrooesophageal reflux disease) and covid-19 (Prior to vaccination, the patient was diagnosed with COVID-19). Concomitant medications included ethinylestradiol, ferrous fumarate, norethisterone acetate (JUNEL FE), omeprazole, fluoxetine, cetirizine hydrochloride (ZYRTEC).  The patient previously took lorabid and experienced allergies.  On 13Jan2021 17:00, the patient experienced fatigue, fever (101+), muscle aches, joint aches, nausea and headaches. The patient underwent lab tests and procedures on 14Jan2021 which included nasal swab: negative.  The outcome of events was recovered. Patient did not receive any treatment for the events. No follow-up attempts are possible. No further information is expected. Information on the batch/lot number has been obtained.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: This is a spontaneous report from a contactable other hcp (patient). A 48-year-old female patient at same age receive first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 20Jan2021 13:15 on right arm at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported.  The patient experienced extreme fatigue for a few days on 23Jan2021. The outcome of event was recovered. She is not pregnant. There was no treatment AE, no covid prior vaccination and no covid tested post vaccination. Information about Batch/Lot number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Throat irritation
Clinical narrative: This is a spontaneous report from a non-contactable healthcare professional. An 87-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EN5318), intramuscular in right arm, on 25Jan2021, at a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. During her 15-minute waiting period after the injection on 25Jan2021, the patient began to experience burning in her throat. The patient denied difficulty breathing, difficulty swallowing, and throat tightness. They were monitoring the patient for severe reaction symptoms, including but not limited to treatment including antihistamines. Follow-up response to treatment was good. The patient was discharged - stable to go home and was asked to follow-up with primary care physician for rapid progression of symptoms and respiratory distress (if observed). The patient recovered from the event on 25Jan2021. No follow-up attempts are possible. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). This 39-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiry date unknown), intramuscular in left deltoid in Jan2021 (reported as 06Jan2021 or 07Jan2021 at 11:30) at a single dose for COVID-19 immunization. There were no medical history and concomitant medications. The patient received the first dose of bnt162b2 on 16Dec2020 at around 19:30, intramuscular injection in left deltoid. A day after vaccination, since an unspecified date in Jan2021, the patient's lymph nodes were swollen for 3 weeks at the time of report. The swelling went down some but was still very noticeable. Outcome of the event was recovering. Event did not require a visit to emergency room or physician office. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Information on the lot/batch number has been requested.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: This is a spontaneous report from a contactable other health care professional (patient self-reported). A 29-year-old female patient (who was not pregnant at the time of vaccination), received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number; EL3247 and expiry date was not provided), via an unspecified route of administration, at arm Right on 26Jan2021, at a single dose for COVID-19 immunization, in Workplace clinic. Patient's medical history was reported as none and concomitant medications were not reported. Patient had no allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was not received any other vaccines within 2 weeks of vaccination of COVID vaccine. On same day (26Jan2021), the patient experienced soreness in right arm and it is persistent after 24hours. Patient was not received any treatment for the event. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Seriousness of the event was reported as non serious. Outcome of the event was recovering.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache; This is a spontaneous report from a contactable consumer (patient herself).  A non-pregnant (not pregnant at the time of vaccination) 49-year-old female patient received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, lot number: EL3247), at age 49 years, via an unspecified route of administration on the left arm, first dose on 26Jan2021 13:15 at single dose, for COVID-19 immunization. Medical history included allergy to Neoprene and had contact dermatitis due to it on an unspecified date. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient received no other medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient's concomitant medications were not reported. The patient experienced headache 26Jan2021 20:00. Facility where the most recent COVID-19 vaccine was administered was at a workplace clinic. Since the vaccination, the patient has not been tested for COVID-19. Therapeutic measures were taken as a result of headache which includes ibuprofen (ADVIL). The outcome of the event was recovered on an unspecified date. Case was reported as non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Ear pain, Headache, Malaise, Pain in extremity
Clinical narrative: generalized malaise; arm pain; headache; earache; This is a spontaneous report from contactable consumer reported for his cousin via Representative. A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on unspecified date at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced arm pain, headache, earache and generalized malaise. The outcome was unknown.  Information on the Lot/Batch number has been requested
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 76-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on right arm on 21Jan2021 at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported.  The patient experienced sore arm on Jan2021. It still fets sore only if she presses on it. The outcome of event was unknown. Information about batch/lot number has been requested.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Eye irritation, Fatigue
Clinical narrative: A 74-years-old female patient received BNT162B2 Pfizer-BioNTech COVID-19 mRNA Vaccine, via an unspecified route of administration on 27Jan2021, at 74 yeras of age, at single dose for COVID-19 immunization. The patient's medical history included allergy to codine. The patient was not pregnant at the time of vaccination. The patient has not been tested for COVID-19 since the vaccination. Concomitant medication included fluoxetine hydrochloride (PROZAC). On 27Jan2021 by 15:00 the patient felt extremely tired and her eyes burned a lot. The reported events resolved on an unknown date without any treatment. . Information on the lot/batch number has been requested.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Lethargy, Pain
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 61-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number EL1284) on 26Jan2021 13:15 at single dose in left arm for COVID-19 immunisation. Age at vaccination was 61 years. The vaccine was administered at Doctor's office/urgent care. No other vaccine was given within 4 weeks prior to the COVID vaccine. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number EL1284) received on 05Jan2021 at 01:30 PM at single dose in left arm and the patient experienced sore arm. Medical history included Supraventricular tachycardia (SVT), Herpes, Hyperlipidemia, idiopathic mesenteric lymphadenopathy. The patient has no known allergies to medications, food, or other products. Concomitant medications included Valacyclovir, cyclobenzaprine, Metoprolol, lipitor. The patient reported second dose 8 hours post headache, sore arm and entire upper torso pain, chills and fever 101-102F 12 hrs. Patient was lethargic the whole next day with severe headache. Normal 2nd day after. Adverse events start date was reported as 26Jan2021 16:00. No treatment was received for the events. The events were reported as non serious. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, has not been tested for COVID-19. The events were resolving (as reported).
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 61-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number EL1284) on 26Jan2021 13:15 at single dose in left arm for COVID-19 immunisation. Age at vaccination was 61 years. The vaccine was administered at Doctor's office/urgent care. No other vaccine was given within 4 weeks prior to the COVID vaccine. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number EL1284) received on 05Jan2021 at 01:30 PM at single dose in left arm and the patient experienced sore arm. Medical history included Supraventricular tachycardia (SVT), Herpes, Hyperlipidemia, idiopathic mesenteric lymphadenopathy. The patient has no known allergies to medications, food, or other products. Concomitant medications included Valacyclovir, cyclobenzaprine, Metoprolol, lipitor. The patient reported second dose 8 hours post headache, sore arm and entire upper torso pain, chills and fever 101-102F 12 hrs. Patient was lethargic the whole next day with severe headache. Normal 2nd day after. Adverse events start date was reported as 26Jan2021 16:00. No treatment was received for the events. The events were reported as non serious. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, has not been tested for COVID-19. The events were resolving (as reported).
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: This is a spontaneous report from a contactable consumer (patient).  A female patient of an unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 25Jan2021 at single dose for COVID-19 immunisation. The patient medical history and the concomitant medications were not reported. The patient previously received first dose of BNT162B2 on 5Jan2021 at single dose for COVID-19 immunisation. The patient received the Dose 1 of the Pfizer-BioNTech COVID-19 Vaccine last 05Jan2021, and Dose 2 on 25Jan2021. She mentioned that she was not sure if the second dose was administered properly. She "isn't sure" she received her second dose correctly. She was worried because, she stated, "I have lower efficacy because I'm on Budesonide." She was calling to ask if it is possible to get a third dose and if so, how long would it be before she could get it. She states she had a sore arm after the second dose. The event was assessed non-serious. Information about lot/batch has been requested.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Vaccination site pain
Clinical narrative: This is a spontaneous report from a non-contactable nurse (patient herself). This 53-year-old female nurse received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unknown route, in Dec2020 at a single dose for COVID-19 immunisation. No relevant medical history and concomitant medications were provided. After the first shot she had moderate pain at injection site for a few days, and fatigue for at least one day. The events were assessed as non-serious. Both events resolved on unknown date. No follow-up attempts are possible. No further information is expected. Information about lot/batch cannot be obtained.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain in extremity, Pyrexia, SARS-CoV-2 antibody test, SARS-CoV-2 antibody test positive
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 63-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) Batch/lot number: EK9231, intramuscularly into the left arm on 05Jan2021 at single dose for covid-19 vaccination. Medical history included in Dec2020 around 23Dec2020 she tested positive for Covid-19. There were no concomitant medications. Patient said that because of the time of her retirement, she went to the VA and got the vaccination the first week of Jan2021. She said that with the first vaccination she said that she had chills, fever, and her arm hurt real bad. She said that her symptoms came on during the night. She mentioned she had experienced some side effects which went away after a few days. She had herself tested last 06Jan2021 (also reported as 07Jan2021, pending for clarification) for Covid-19 antibodies which turned out positive and PCR which turned out negative. The outcome of the event "Covid antibodies which turned out positive" was unknown, while outcome of other events was recovered in Jan2021.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 63-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) Batch/lot number: EK9231, intramuscularly into the left arm on 05Jan2021 at single dose for covid-19 vaccination. Medical history included in Dec2020 around 23Dec2020 she tested positive for Covid-19. There were no concomitant medications. Patient said that because of the time of her retirement, she went to the VA and got the vaccination the first week of Jan2021. She said that with the first vaccination she said that she had chills, fever, and her arm hurt real bad. She said that her symptoms came on during the night. She mentioned she had experienced some side effects which went away after a few days. She had herself tested last 06Jan2021 (also reported as 07Jan2021, pending for clarification) for Covid-19 antibodies which turned out positive and PCR which turned out negative. The outcome of the event "Covid antibodies which turned out positive" was unknown, while outcome of other events was recovered in Jan2021.
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective
Clinical narrative: Before his 2nd dose, he was diagnosed with COVID and was given bamlanivimab; Before his 2nd dose, he was diagnosed with COVID and was given bamlanivimab; This is a spontaneous report from a contactable consumer. A male patient of unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) at single dose on an unspecified date for COVID-19 immunisation. Medical history and concomitant medication were not reported. Patient received 1st dose of vaccine.  Before his 2nd dose, he was diagnosed with COVID and was given bamlanivimab. It was planned to wait 90 days before giving him any additional vaccine. Reporter also asked should patient receive one more dose or restart the series. The outcome of events was unknown.   Information about Lot/Batch has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Headache
Clinical narrative: diarrhea; headache; This is a spontaneous report from a Non-contactable consumer (patient). A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 28Jan2021 at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported.  The patient experienced diarrhea and headache both on 28Jan2021. The outcome was unknown.        No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Pain in arm; This is a spontaneous report from a contactable consumer (patient). A 53-year-old male patient received the first dose of bnt162b2 (BNT162B2, lot number and expiry date were not reported), via an unspecified route of administration, on 26Jan2021 08:00 AM at a single dose on the left arm for COVID-19 immunization. The most recent COVID-19 vaccine was administered at a hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Medical history was none. The patient had no known allergies to medications, food, or other products. The patient had no concomitant medications. On 26Jan2021 02:00 PM, the patient experienced pain in arm. No treatment was received for the event. Outcome of the event was recovering. Since the vaccination, the patient has not been tested for COVID-19. The reporter assessed the event as non-serious.   Information on the lot/batch number has been requested.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Pain on injection site; This is a spontaneous report from a contactable consumer (patient). A 47-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunization.  Medical history type 1 diabetes. The patient's concomitant medications were not reported.  The patient experienced pain on injection site 18 hours following first dose of BNT162b2 COVID-19 vaccine.  The outcome was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Vaccination site pain
Clinical narrative: Sore arm at the injection site; slight headache; This is a spontaneous report from a contactable consumer (Pfizer colleague) reported for herself. A 33-year-old female patient (not pregnant at the time of vaccination) received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3247), via an unspecified route of administration at left arm on 28Jan2021 09:30 at SINGLE DOSE for covid-19 immunization.  Medical history was none. There were no allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient's concomitant medications were not reported. The patient had no other medications received within 2 weeks of vaccination. The patient experienced sore arm at the injection site, and a slight headache both on 29Jan2021. The patient did not receive treatment for the adverse event. Since the vaccination, the patient had not been tested for COVID-19. The outcome was recovering. The seriousness from reporter was non-serious.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Headache, Nausea, Pain
Clinical narrative: Experienced loss of appetite; mild nausea; headache; very mild body aches; This is a spontaneous report from a contactable consumer (patient). A 25-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE solution for injection; lot number: EL3247; expiry date: unknown) via an unspecified route of administration in the left arm, on 28Jan2021 at 09:15, at a single dose, for COVID 19 immunization. The patient had no relevant medical history and had no known allergies. Concomitant medication included ethinylestradiol, ferrous fumarate, norethisterone acetate (BLISOVI 24 FE). It was unknown if the patient is pregnant at the time of vaccination. The patient was not diagnosed with COVID prior vaccination. The patient did not receive other vaccines within four weeks prior to COVID vaccination. The vaccine was administered in the workplace clinic. On 28Jan2021, at 18:00, the patient experienced loss of appetite/mild nausea, headache, and very mild body aches. The events were considered non-serious. The patient did not receive treatment for the events. Outcome of the events was recovering/resolving. The patient has not been tested for COVID-19 since vaccination.